Respiratory

Vaccination against Respiratory Syncytial Virus (RSV) Begins on September 25, Protecting Children from Respiratory Infections

by
Vaccination against Respiratory Syncytial Virus (RSV) Begins on September 25, Protecting Children from Respiratory Infections

Vaccination against Respiratory Syncytial Virus (RSV) will begin on September 25, as it treats the main cause of respiratory tract infections such as bronchiolitis or pneumonia. Since last Thursday, September 15 Parents have begun to receive appointments to vaccinate children under six months of age. The total doses contracted for the 2023-2024 campaign are 63,600, … Read more

MIS-C in children: A distinct autoimmune response to COVID-19 targeting SNX8 and SARS-CoV-2 nucleocapsid protein domain

by
MIS-C in children: A distinct autoimmune response to COVID-19 targeting SNX8 and SARS-CoV-2 nucleocapsid protein domain

In a recent study published on the preprint server medRxiv, researchers analyzed a large dataset of children with multisystem inflammatory syndrome (MIS-C) to determine whether their autoantibodies target a different set of host proteins than healthy controls. The researchers aimed to determine whether fine epitope matching between SARS-CoV-2 and the SNX8 protein is associated with … Read more

New study reveals successful treatment of rare human infection caused by Pasteurella multocida

by
New study reveals successful treatment of rare human infection caused by Pasteurella multocida

A recent study published in the Zoonoses journal sheds new light on Pasteurella multocida infections in humans. The Gram-negative, penicillin-sensitive coccobacillus is typically found in animals’ respiratory microbiota and can cause severe disease in humans, particularly those with cirrhosis or compromised immune systems. Although P. multocida infections are typically associated with animal bites, this study … Read more

Respiratory syncytial virus vaccine for adults marks a turning point

by
Respiratory syncytial virus vaccine for adults marks a turning point

The candidate vaccine againstrespiratory syncytial virus (VRS)for people over 60 years of age that are being developed by different international groups for the pharmaceutical company GSK, and in which researchers from the Santiago Clinic participate, is called to be “a turning point for other vaccines and in the treatment of this disease in adults”. As … Read more

Epidemiologist: “Congestions from transport, kindergartens and schools favor the transmission of respiratory infections”

by
Epidemiologist: “Congestions from transport, kindergartens and schools favor the transmission of respiratory infections”

Specialists explain the return to the situation before the Covid-19 pandemic by the fact that people have stopped complying with preventive measures: wearing a mask, washing hands and maintaining social distance. Europa Liberă spoke with the epidemiologist Angela Paraschiv, head of the Epidemiology discipline at the “Nicolae Testemițanu” University of Medicine and Pharmacy, about the … Read more